Structure |
Chemical Name |
CAS |
MF |
|
Olaparib Impurity A |
|
|
|
Dapoxetine Impurity 2 |
|
|
|
Voriconazole Impurity 5 |
|
|
|
tetrahydrofuran-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate |
1404453-75-3 |
C17H22O4 |
|
Lamivudine impurity 5 |
|
|
|
Clopidogrel Impurity 2 |
|
C15H14ClNO2S |
|
Mirabegron Impurity 6 |
2762802-64-0 |
C10H11ClN4O3S2 |
|
Pitavastatin Impurity 3 |
|
|
|
Solifenacin EP Impurity D |
|
|
|
Cephalexin Impurity 2 |
|
C16H17N3O4S |
|
Cefuroxime Impurity 3 |
|
C16H16N4O8S |
|
Vonoprazan Impurity 11 |
|
|
|
Erlotinib Imp.14 |
|
|
|
Sorafenib related compound 12 |
284461-74-1 |
C20H14ClF3N4O3 |
|
(1R,3S)-Solifenacin Succinate |
774517-20-3 |
C23H26N2O2 |
|
Dacpomycin Impurity 2 |
|
|
|
Nicorandil Impurity 3 |
|
|
|
Tacrolimus Impurity A |
|
|
|
1H-Benz[de]isoquinolin-1-one,2-(3S)-1-azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-,(3aR)- |
135729-73-6 |
C19H24N2O |
|
Mirabegron Impurity 19 |
|
|
|
(Z)-Mutagenic Impurity of Tenofovir Disoproxil |
1464851-21-5 |
C8H9N5 |
|
Moxifloxacin impurity (20) |
|
|
|
(R)-2-(2-(tert-butoxy)-2-oxoethyl)pentanoic acid |
112106-16-8 |
C11H20O4 |
|
Bazedoxifene impurity |
|
|
|
Tamsulosin impurity |
|
C20H28N2O5S |
|
Clarithromycin (9Z)-Oxime |
127253-05-8 |
C38H70N2O13 |
|
N-Desmethyl Clarithromycin (9E)-Oxime |
127182-43-8 |
C37H68N2O13 |
|
Ticagrelor Impurity 24 |
1482484-92-3 |
C7H11N3O2S |
|
Moxifloxacin Impurity |
1797982-51-4 |
C16H16FNO5 |
|
sofosBuvir impurity 1 |
|
|
|
2-(3-cyano-4-isopropoxyphenyl)-4-methylthiazole-5-carboxylic acid |
144060-52-6 |
C15H14N2O3S |
|
R-Tirofiban |
158808-86-7 |
C22H36N2O5S |
|
Canagliflozin Impurity 20 |
|
|
|
Canagliflozin Impurity 6 |
|
|
|
Carfilzomib Impurity 6 |
|
|
|
Daclatasvir Impurity 5 (SRSS-Isomer) |
1009117-28-5 |
C40H50N8O6 |
|
Dolutegravir Impurity 7 |
2244161-71-3 |
C20H21N3O5 |
|
Istradefylline Impurity F |
|
|
|
Linagliptin Impurity 22 |
|
|
|
Nintedanib impurity G |
894783-61-0 |
C30H31N5O4 |
|
3,3′-[(2-methylbenzene-1,3-diyl)bis(oxy)]bis(N-methyl- 3-phenylpropan-1-amine) |
1010818-93-5 |
C27H34N2O2 |
|
Febuxostat impurity 36 |
1805770-40-4 |
C12H12N2O |
|
N-[1-[(3R)-1-(1-oxo-2-propen-1-yl)-3-piperidinyl]-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]- 2-Propenamide |
2031255-27-1 |
C28H26N6O3 |
|
4-amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one |
|
C8H11FN3O4S- |
|
Cephalexin Impurity 4 |
|
C16H17N3O4S |
|
Rivaroxaban Impurity 42 |
|
|
|
(R,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3-hydroxy-5-oxohept-6-enoic acid |
1422514-05-3 |
C22H26FN3O6S |
|
Cabozantinib Impurity C |
|
|
|
(3R,4R)-N,4-dimethyl-piperidin-3-amine |
1354469-76-3 |
C7H16N2 |
|
4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine |
952518-97-7 |
C9H7N5 |
|
5-phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde |
881676-90-0 |
C16H12N2O3S |
|
3-Piperidinemethanol, 4-(4-fluorophenyl)-1-methyl-, (3R,4R)- |
100332-12-5 |
C13H18FNO |
|
Pyridine, 4-chloro-2-(chloromethyl)-3-methyl- |
168167-48-4 |
C7H7Cl2N |
|
1,2,4-Triazolo(3,4-b)benzothiazole-5-methanol |
69243-49-8 |
C9H7N3OS |
|
Benzoicacid, 2-sulfino- |
13165-80-5 |
C7H6O4S |
|
Benzenemethanamine, a-ethyl-N,N-dimethyl- |
3330-05-0 |
C11H17N |
|
CIS-1,2-BIS(AMINOMETHYL)CYCLOBUTANE |
15286-88-1 |
C6H14N2 |
|
N-FORMYL-1-(2-AMINO-1-(4-METHOXYPHENYL)ETHYL)CYCLOHEXANOL |
272788-07-5 |
C16H23NO3 |
|
Acotiamide Impurity |
198470-83-6 |
C20H21N2NaO4S |
|
Terbutaline Impurity |
52144-90-8 |
C26H29NO3 |
|
methyl (41S,12R,13aR)-13a-ethyl-12-
hydroxy-2,3,41,5,6,12,13,13aoctahydro-
1H-indolo[3,2,1-
de]pyrido[3,2,1-ij][1,5]naphthyridine-
12-carboxylate |
83508-83-2 |
C21H26N2O3 |
|
ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate |
473465-11-1 |
C18H18N2O3S |
|
Ropivacaine-iPr-R |
1050482-18-2 |
C17H26N2O |
|
Demiditraz IMpurity |
944268-66-0 |
C20H22N2O |
|
Betamethasone EP Impurity H |
185613-71-2 |
C22H29FO5 |
|
Blonanserin Impurity 10 |
132810-87-8 |
C23H30ClN3 |
|
Blonanserin impurity G |
|
|
|
Cefodizime Impurity 5 |
|
|
|
Clindamycin Impurity 4 |
|
|
|
Doxofylline Impurity 4 |
2095554-12-2 |
C11H16N4O5 |
|
Eltrombopag Impurity 1 |
1246929-02-1 |
C25H23N5O3 |
|
Everolimus impurity A |
|
|
|
Fosaprepitant Impurity 13 |
|
|
|
Gefitinib Impurity J |
|
|
|
Isavuconazole Impurity 23 |
|
|
|
Isavuconazole Impurity 29 |
|
|
|
Isavuconazole Impurity 7 |
|
|
|
Lercanidipine Impurity 6 |
786625-22-7 |
C37H43N3O6 |
|
Linagliptin Impurity 43 |
|
|
|
MiraBegron Impurity A |
|
|
|
Moxifloxacin Impurity 15 |
|
|
|
Moxifloxacin Impurity 32 |
|
|
|
Nifedipine Impurity F |
53055-15-5 |
C18H20N2O6 |
|
Olaparib Impurity 15 |
2250243-17-3 |
C24H25FN4O3 |
|
Olopatadine Impurity 4 |
55690-15-8 |
C18H18O5 |
|
Posaconazole Impurity 26 |
|
|
|
Posaconazole Impurity 48 |
1902954-03-3 |
C37H42F2N8O5 |
|
Posaconazole Impurity 9 |
|
|
|
Roxithromycin Impurity E |
|
|
|
SofosBuvir impurity 48 |
|
|
|
SofosBuvir Impurity 54 |
1431932-81-8 |
C12H17ClNO4P |
|
Timolol EP Impurity G |
75202-36-7 |
C6H9N3O3S |
|
Tofacitinib Impurity 44 |
2374700-39-5 |
C13H19N5 |
|
Trelagliptin Impurity 24 |
|
|
|
dimethyl 3- isobutylpentanedioate |
145328-03-6 |
C11H20O4 |
|
Phenol, 4-chloro-3-[(4-ethoxyphenyl)methyl]- |
1408077-50-8 |
C15H15ClO2 |
|
2-amino-9-((3aS,4S,6S,6aR)-3a,6-dihydroxyhexahydro-1H-cyclopenta[c]furan-4-yl)-1,9-dihydro-6H-purin-6-one |
1984788-96-6 |
C12H15N5O4 |
|
Ampicillin Impurity C |
|
|
|
Ampicillin Impurity O |
|
|
|
(4R,5R,6S)-4-nitrobenzyl 6-((R)-1-hydroxyethyl)-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate |
104873-15-6 |
C17H18N2O7 |